MENU
+Compare
ZVSA
Stock ticker: NASDAQ
AS OF
Jun 6 closing price
Price
$0.65
Change
-$0.00 (-0.00%)
Capitalization
3.13M

ZVSA ZyVersa Therapeutics Forecast, Technical & Fundamental Analysis

ZyVersa Therapeutics Inc is a clinical-stage biopharmaceutical company leveraging proprietary technologies to develop drugs for patients with chronic renal or inflammatory diseases with high unmet medical needs... Show more

ZVSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ZVSA with price predictions
Jun 06, 2025

ZVSA in +5.53% Uptrend, rising for three consecutive days on June 06, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where ZVSA advanced for three days, in of 76 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on May 23, 2025. You may want to consider a long position or call options on ZVSA as a result. In of 62 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ZVSA just turned positive on May 20, 2025. Looking at past instances where ZVSA's MACD turned positive, the stock continued to rise in of 25 cases over the following month. The odds of a continued upward trend are .

ZVSA moved above its 50-day moving average on June 06, 2025 date and that indicates a change from a downward trend to an upward trend.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 14 cases where ZVSA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ZVSA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ZVSA broke above its upper Bollinger Band on May 29, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ZVSA entered a downward trend on May 20, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.384) is normal, around the industry mean (16.648). P/E Ratio (0.001) is within average values for comparable stocks, (59.923). ZVSA's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.234). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (260.036).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ZVSA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ZVSA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ZVSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2200 North Commerce Parkway
Phone
+1 754 231-1688
Employees
7
Web
https://www.zyversa.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DDD1.730.06
+3.59%
3D Systems Corp
WPRT2.880.05
+1.77%
Westport Fuel Systems
SCI79.241.01
+1.29%
Service Corp
SYNA62.560.75
+1.21%
Synaptics
QLGN3.75-0.06
-1.57%
Qualigen Therapeutics Inc

ZVSA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ZVSA has been loosely correlated with CGEM. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ZVSA jumps, then CGEM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZVSA
1D Price
Change %
ZVSA100%
+1.50%
CGEM - ZVSA
34%
Loosely correlated
+3.89%
PHIO - ZVSA
29%
Poorly correlated
+20.33%
SYRE - ZVSA
28%
Poorly correlated
+2.11%
REVB - ZVSA
27%
Poorly correlated
+5.45%
ANVS - ZVSA
26%
Poorly correlated
+5.25%
More